| PERIOD ENDING | 28-Feb-09 | 29-Feb-08 | 28-Feb-07 | | Total Revenue |
-
|
-
|
-
| | Cost of Revenue | 13,612 | 336 | 172 | | | Gross Profit | (13,612) | (336) | (172) | | | Operating Expenses | | Research Development |
-
|
-
|
-
| | Selling General and Administrative | 4,566 | 1,598 | 1,104 | | Non Recurring |
-
|
-
|
-
| | Others | 33 | 3 | 3 | | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | (18,211) | (1,937) | (1,279) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 1,214 | (9,954) | (7,041) | | Earnings Before Interest And Taxes | (16,997) | (1,408) | (1,552) | | Interest Expense |
-
|
-
|
-
| | Income Before Tax | (16,997) | (1,408) | (1,552) | | Income Tax Expense |
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | (16,997) | (11,891) | (8,320) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (16,997) | (11,891) | (8,320) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($16,997) | ($11,891) | ($8,320) |
|
0.03% Nasdaq 
0.03 (3.56%) 
Income Statement
